Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Calculated transaction value
$1.29M

Rothblatt Martine A Chairperson & CEO

Transaction date Jul 16, 2026
Public filing date Jul 17, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$529.05 Jul 16, 2026
First close after public filing
$529.34 Jul 20, 2026
30-day return after filing
-3.94% Through Aug 17, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
9,500 shares @ $135.42
SEC ownership
Indirect
Transaction code
M
Form
4
Filing identifier
0001106578-26-000100
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.33M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Current Exercise Jul 16, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jul 16, 2026 $42.19K
United Therapeutics Corp UTHR Sale Jul 16, 2026 $739.78K
United Therapeutics Corp UTHR Sale Jul 16, 2026 $1.62M
United Therapeutics Corp UTHR Sale Jul 16, 2026 $1.02M
United Therapeutics Corp UTHR Sale Jul 16, 2026 $276.71K
United Therapeutics Corp UTHR Sale Jul 16, 2026 $234.64K
United Therapeutics Corp UTHR Sale Jul 16, 2026 $640.1K
United Therapeutics Corp UTHR Sale Jul 16, 2026 $385.34K
United Therapeutics Corp UTHR Sale Jul 16, 2026 $80.44K
United Therapeutics Corp UTHR Sale Jul 16, 2026 $5.91K
United Therapeutics Corp UTHR Exercise Jul 16, 2026 $0